Last10K.com

Aethlon Medical Inc (AEMD) SEC Filing 10-K Annual report for the fiscal year ending Friday, March 31, 2017

Aethlon Medical Inc

HISTORY TOOLS
CIK: 882291 Ticker: AEMD
Document And Entity Information - USD ($)
12 Months Ended
Mar. 31, 2017
Jun. 28, 2017
Sep. 30, 2016
Aggregate maximum liquidated damages amount   
Entity Registrant NameAethlon Medical Inc  
Entity Central Index Key0000882291  
Document Type10-K  
Document Period End DateMar. 31, 2017  
Amendment Flagfalse  
Current Fiscal Year End Date--03-31  
Is Entity a Well-known Seasoned Issuer?No  
Is Entity a Voluntary Filer?No  
Is Entity's Reporting Status Current?Yes  
Entity Filer CategorySmaller Reporting Company  
Entity Public Float  $ 27,000,000
Entity Common Stock, Shares Outstanding 8,869,571 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2017  

View differences made from one year to another to evaluate Aethlon Medical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aethlon Medical Inc.

Continue

Assess how Aethlon Medical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aethlon Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Equity (deficit)
Consolidated Statements Of Operations
1. Organization And Summary Of Significant Accounting Policies (details Narrative)
1. Organization And Summary Of Significant Accounting Policies (details)
1. Organization, Liquidity And Summary Of Significant Accounting Policies
1. Organization, Liquidity And Summary Of Significant Accounting Policies (policies)
1. Organization, Liquidity And Summary Of Significant Accounting Policies (tables)
10. Segments
10. Segments (details)
10. Segments (tables)
11. Subsequent Events
12. Commitments And Contingencies
12. Commitments And Contingencies (details -rent)
12. Commitments And Contingencies (details Narrative)
12. Commitments And Contingencies (tables)
2. Property And Equipment
2. Property And Equipment (details Narrative)
2. Property And Equipment (details)
2. Property And Equipment (tables)
3. Patents
3. Patents (details Narrative)
3. Patents (details)
3. Patents (tables)
4. Convertible Notes Payable
4. Convertible Notes Payable (details - Convertible Note Activity)
4. Convertible Notes Payable (details - Convertible Notes)
4. Convertible Notes Payable (details Narrative)
4. Convertible Notes Payable (tables)
5. Equity Transactions
5. Equity Transactions (details - Option Activity)
5. Equity Transactions (details - Options Exercisable)
5. Equity Transactions (details - Rsu's Outstanding)
5. Equity Transactions (details - Stockbased Compensation)
5. Equity Transactions (details - Warrant Activity)
5. Equity Transactions (details - Warrant Assumptions)
5. Equity Transactions (details - Warrants Exercisable)
5. Equity Transactions (details Narrative)
5. Equity Transactions (tables)
6. Related Party Transactions
6. Related Party Transactions (details Narrative)
7. Other Current Liabilities
7. Other Current Liabilities (details)
7. Other Current Liabilities (tables)
8. Income Taxes
8. Income Taxes (details - Deferred Tax Assets)
8. Income Taxes (details - Provision For Income Taxes)
8. Income Taxes (details Narrative)
8. Income Taxes (tables)
9. Darpa Contract And Related Revenue Recognition
9. Darpa Contract And Related Revenue Recognition (details Narrative)
Document And Entity Information
Ticker: AEMD
CIK: 882291
Form Type: 10-K Annual Report
Accession Number: 0001683168-17-001671
Submitted to the SEC: Wed Jun 28 2017 5:21:14 PM EST
Accepted by the SEC: Wed Jun 28 2017
Period: Friday, March 31, 2017
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aemd/0001683168-17-001671.htm